1. Home
  2. MYNZ vs GRNQ Comparison

MYNZ vs GRNQ Comparison

Compare MYNZ & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • GRNQ
  • Stock Information
  • Founded
  • MYNZ 2021
  • GRNQ 2013
  • Country
  • MYNZ Germany
  • GRNQ Malaysia
  • Employees
  • MYNZ N/A
  • GRNQ N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • GRNQ EDP Services
  • Sector
  • MYNZ Health Care
  • GRNQ Technology
  • Exchange
  • MYNZ Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • MYNZ 5.5M
  • GRNQ 11.9M
  • IPO Year
  • MYNZ 2021
  • GRNQ 2018
  • Fundamental
  • Price
  • MYNZ $1.44
  • GRNQ N/A
  • Analyst Decision
  • MYNZ Buy
  • GRNQ
  • Analyst Count
  • MYNZ 2
  • GRNQ 0
  • Target Price
  • MYNZ $14.00
  • GRNQ N/A
  • AVG Volume (30 Days)
  • MYNZ 119.0K
  • GRNQ 80.1K
  • Earning Date
  • MYNZ 07-15-2025
  • GRNQ 08-12-2025
  • Dividend Yield
  • MYNZ N/A
  • GRNQ N/A
  • EPS Growth
  • MYNZ N/A
  • GRNQ N/A
  • EPS
  • MYNZ N/A
  • GRNQ N/A
  • Revenue
  • MYNZ $893,991.00
  • GRNQ $3,190,761.00
  • Revenue This Year
  • MYNZ $26.06
  • GRNQ N/A
  • Revenue Next Year
  • MYNZ $4.97
  • GRNQ N/A
  • P/E Ratio
  • MYNZ N/A
  • GRNQ N/A
  • Revenue Growth
  • MYNZ N/A
  • GRNQ N/A
  • 52 Week Low
  • MYNZ $1.34
  • GRNQ $0.80
  • 52 Week High
  • MYNZ $22.40
  • GRNQ $2.24
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 26.61
  • GRNQ 60.69
  • Support Level
  • MYNZ $1.35
  • GRNQ $1.52
  • Resistance Level
  • MYNZ $1.46
  • GRNQ $1.68
  • Average True Range (ATR)
  • MYNZ 0.12
  • GRNQ 0.16
  • MACD
  • MYNZ 0.02
  • GRNQ -0.02
  • Stochastic Oscillator
  • MYNZ 9.27
  • GRNQ 30.00

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

Share on Social Networks: